Rémy Cointreau's price target has been lowered by UBS from €71 to €65, with a 'neutral' rating on the stock. This adjustment reflects an 8% upside potential for the French spirits company.
The brokerage has revised its expected earnings per share (EPS) for fiscal years 2025, 2026, and 2027 down by approximately 18%, 24%, and 18%, respectively. The revisions are attributed to a slower-than-anticipated recovery in the U.S. market and the adverse effects of tariffs on cognac exports to China, which are expected to impact margins in fiscal 2026.
Investors should take these factors into consideration when evaluating their positions in Rémy Cointreau.